Keun Hyung Park Selected Research

Endotoxemia

7/2015

Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-κB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keun Hyung Park Research Topics

Disease

2	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2014 - 03/2014
1	COVID-19 11/2021
1	Chronic Renal Insufficiency 11/2020
1	Neoplasms (Cancer) 03/2018
1	Necrosis 03/2018
1	Endotoxemia 07/2015
1	Septic Shock (Toxic Shock Syndrome) 07/2015
1	Pain (Aches) 07/2014
1	Gastroenteritis 07/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2014
1	Inflammation (Inflammations) 06/2013
1	Hypoxia (Hypoxemia) 06/2013
1	Stomatitis 01/2013

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 03/2018 - 07/2015
2	Proteins (Proteins, Gene)FDA Link 07/2014 - 03/2014
1	CosmeticsIBA 11/2021
1	C-Reactive ProteinIBA 11/2020
1	Chemotactic FactorsIBA 03/2018
1	InterleukinsIBA 03/2018
1	cynandione AIBA 07/2015
1	LipopolysaccharidesIBA 07/2015
1	Interleukin-6 (Interleukin 6)IBA 07/2015
1	Biological ProductsIBA 07/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2014
1	Caspase 3 (Caspase-3)IBA 03/2014
1	JNK Mitogen-Activated Protein KinasesIBA 03/2014
1	ChemokinesIBA 06/2013
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2013
1	Therapeutic UsesIBA 01/2013
1	TeaIBA 01/2013
1	Catechin (Z 7300)IBA 01/2013

Therapy/Procedure

2	Radiotherapy 07/2014 - 03/2014
1	Traditional Medicine (Folk Remedies) 07/2014
1	Oral Administration 01/2013